WENTWORTH KORY JAMES 4
4 · Entrada Therapeutics, Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Entrada Therapeutics CFO Kory J. Wentworth Sells 7,988 Shares
What Happened
Kory J. Wentworth, Chief Financial Officer of Entrada Therapeutics (TRDA), sold 7,988 shares in an open-market sale. The reported weighted-average price was $12.25 per share, for aggregate proceeds of approximately $97,892. The sale was reported on Form 4 covering transactions on March 4, 2026.
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (appears timely).
- Shares sold: 7,988; weighted-average price: $12.25; total proceeds: ~$97,892.
- Price range: sales executed at prices between $11.80 and $12.57 (multiple trades); the filer can provide per-price breakdown on request (see footnote).
- Footnote: Transactions were made under a Rule 10b5-1 trading plan adopted March 6, 2025.
- Shares owned after the transaction: not disclosed in the information provided.
Context
A sale by an executive is often routine (e.g., planned selling under a 10b5-1 plan) and does not by itself indicate the company’s prospects. The 10b5-1 plan note confirms these trades were pre-planned; the price range note indicates multiple executions. Retail investors should view this as a scheduled insider sale rather than an ad hoc sign of sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-04$12.25/sh−7,988$97,892→ 137,987 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $12.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.